Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
Abilify for off-label uses. The Food and Drug Administration (FDA) has approved Abilify to treat adult schizophrenia and bi-polar disorder
Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
Abilify and Death in the Elderly: In 2024, the FDA requested that antipsychotic drugs, including Abilify, update their labels to include a Black Box Warning
Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
The FDA-approved drug labels for aripiprazole (ABILIFY and ABILIFY MAINTENA), provide dosage adjustments for patients who are CYP2D6 poor metabolizers (PMs).
Our Abilify lawyers are currently accepting cases involving compulsive behavior. The FDA recently added warnings to Abilify's labels
Abilify – aripiprazole (View the FDA label) Uses Side Effects Precautions Interactions Overdose.
Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
Comments
What the hell would the FDA have to do with it? This is a piece of machinery. They would have NO say about it whatsoever.
Good story - would like to see more!